|
gptkbp:instanceOf
|
gptkb:mental_disorder
gptkb:mood_disorder
|
|
gptkbp:canBeManagedBy
|
gptkb:psychotherapy
gptkb:drug
|
|
gptkbp:class
|
gptkb:DSM-5
gptkb:ICD-10
|
|
gptkbp:complication
|
gptkb:substance_abuse
suicide
occupational impairment
legal problems
relationship difficulties
|
|
gptkbp:diagnosedBy
|
gptkb:DSM-5_criteria
psychiatric evaluation
|
|
gptkbp:differentialDiagnosis
|
gptkb:Bipolar_II_disorder
gptkb:major_depressive_disorder
schizophrenia
borderline personality disorder
|
|
gptkbp:firstDescribed
|
gptkb:Emil_Kraepelin
|
|
gptkbp:hasDepressiveEpisodeDuration
|
at least 2 weeks
|
|
gptkbp:hasManicEpisodeDuration
|
at least 7 days
|
|
gptkbp:hasNoCure
|
true
|
|
gptkbp:ICD-10_code
|
F31.1
|
|
gptkbp:offersCourse
|
episodic
chronic
recurrent
|
|
gptkbp:onset
|
late adolescence to early adulthood
|
|
gptkbp:partOf
|
bipolar spectrum
|
|
gptkbp:prevalence
|
~1% of population
|
|
gptkbp:riskFactor
|
gptkb:substance_abuse
genetic predisposition
stressful life events
family history of bipolar disorder
|
|
gptkbp:symptom
|
psychosis
increased energy
insomnia
suicidal ideation
irritability
impulsivity
decreased need for sleep
grandiosity
racing thoughts
depressive episode
manic episode
|
|
gptkbp:treatment
|
gptkb:psychotherapy
gptkb:carbamazepine
lithium
antipsychotics
electroconvulsive therapy
mood stabilizers
valproate
|
|
gptkbp:bfsParent
|
gptkb:Bipolar_disorder
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bipolar I disorder
|